Article Information
History
- January 24, 2023.
Article Versions
- Version 1 (January 18, 2023 - 20:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Oliver Pain1,*,
- Ashley Jones1,
- Ahmad Al Khleifat1,
- Devika Agarwal2,
- Dzmitry Hramyka3,4,
- Hajer Karoui5,
- Jędrzej Kubica6,7,
- David J. Llewellyn8,9,
- Janice M. Ranson8,
- Zhi Yao10,
- Alfredo Iacoangeli1,11,12 and
- Ammar Al-Chalabi1
- 1Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
- 2Wellcome Centre for Human Genetics, Nuffield Department of Medicine, Old Road Campus, University of Oxford, Oxford, United Kingdom
- 3Core Unit Bioinformatics (CUBI), Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Berlin, Germany
- 4Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
- 5Multiple Sclerosis and Parkinson’s Tissue Bank, Department of Brain Sciences, Imperial College London, London, United Kingdom
- 6Laboratory of Structural Bioinformatics, Institute of Evolutionary Biology, University of Warsaw, Poland
- 7Laboratory of Theory of Biopolimers, Faculty of Chemistry, University of Warsaw, Poland
- 8University of Exeter Medical School, Exeter, United Kingdom
- 9Alan Turing Institute, London, United Kingdom
- 10LifeArc, Stevenage, United Kingdom
- 11Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom
- 12National Institute for Health Research Biomedical Research Centre and Dementia Unit at South London and Maudsley NHS Foundation Trust and King’s College London, London, United Kingdom
- ↵*Corresponding Author:
Oliver Pain (oliver.pain{at}kcl.ac.uk)
Posted January 24, 2023.
Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk Prediction
